NMPSS | NMPSS Blog

New Mexicans deserve access to Psilocybin Therapy

Recent research from leading universities across the world show psychedelic therapy stands to greatly improve the mental health of many patients in need of relief.

By advocating for safe and legal access to psychedelic therapy in New Mexico we hope to:

Establish a regulated system

Expand access to breakthrough therapies

Support and protect our community

You may have seen the press about the promising science of psychedelic therapy and how they can help be a part of the solution to many societal ills. From depression and anxiety, addictions, post traumatic stress disorder (PTSD) and other psychological traumas, to end of life anxiety; to addiction and substance use disorder, early research from top medical research universities shows that psychedelic therapy may help where other treatments have failed.

Here’s what the research says

There is a substantial and rapidly growing body of research finding that entheogenic plants and fungi use can have mental health benefits, societal benefits, and can lead to personal and spiritual growth.

NMPSS Proudly Sponsors “A Better Trip” by Shane Mauss in Albuquerque

April 2, 2024 No Comments

The New Mexico Psychedelic Science Society (NMPSS) is thrilled to announce our sponsorship of the groundbreaking comedy show “A Better Trip” by Shane Mauss, set to take place in Albuquerque on April 4th.

NMPSS Spring Update: Pioneering Progress in Psychedelic Science

April 2, 2024 No Comments

The New Mexico Psychedelic Science Society (NMPSS) has been at the forefront of advocating for safe and equitable access to psychedelic therapies.

Psychedelic Society promotes psilocybin-assisted therapy

August 4, 2022 No Comments

A group of physicians, research scientists, academics and activists is laying the groundwork for state legislation that would allow psilocybin-containing mushrooms to be used for psychedelic-assisted therapy in a clinical setting.

Psychedelic Therapy Facts & Information

Psilocybin in the Treatment of Depression

“All patients showed some reductions in their depression scores at 1-week post-treatment and maximal effects were seen at 5 weeks, with results remaining positive at 3 and 6 months.” Read More…

Source: Beckley/Imperial Research Programme

Low-Risk Dependence of Psilocybin

“[I]n a comparative overview of the dependence potential and acute toxicity of psychoactive substances, Gable concluded that psilocybin carried a lower risk of dependence than caffeine… (Gable, 1993).” Read More…

Source: Neuropharmacology

Frequently Asked Questions

What is psychedelic therapy?

Psychedelic therapy is a therapeutic method involving the administration of a psychedelic drug in a clinical setting. Clinical research shows that ingesting a psychedelic drug in a controlled setting with a trained professional can induce an experience that is medically safe and that provokes profound, durable psychological and behavioral change.

Who stands to benefit from psychedelic therapy?

Recent research shows psychedelic therapy can benefit people suffering from a wide array of challenges. The psychedelic drug psilocybin, when administered in a controlled setting, has been shown to significantly reduce anxiety and depression in cancer patients struggling with an end-of-life diagnosis. Additionally, a variety of psychedelic drugs have shown promise in reducing, and even eliminating, addictive behavior.

How can I become more involved?

Please sign up for our email list at the bottom of this page and like our Facebook page! We will be sending out regular updates with tasks like digital organizing, fundraising, and more.